Clinical characteristics of reported NUT midline carcinomas
| Case no. | Age (years) | Sex | Location | Diagnosis | Survival (months) | BRD4–NUT | NUT-variant | Reference |
| 1 | 3 | M | Bladder | PDSQC | 8.5 | Yes | – | French et al3 |
| 2 | 5 | M | Mediastinum | Mucoepidermoid carcinoma | 3.5 | Yes | – | Lee et al9 |
| 3 | 10 | M | Iliac bone | Ewing sarcoma/PNET | AW/OD 180 | Yes | – | Dang et al18 |
| 4 | 11 | F | Thorax | Undifferentiated carcinoma | 4.5 | Yes | – | Kees et al8 |
| 5 | 12 | F | Nasopharynx | PDSQC | 3.25 | Yes | – | Vargas et al11; French et al19 |
| 6 | 13 | F | Epiglottis | Undifferentiated carcinoma | 9 | Yes | – | Vargas et al11 |
| 7 | 15 | M | Mediastinum | Thymic PDSQC | 6 | Yes | – | Toretsky et al12 |
| 8 | 15 | F | Orbit | PDSQC | 7 | Yes | – | French et al3 |
| 9 | 16 | M | Lung | SQC | 37 | – | Yes | French et al3 |
| 10 | 16 | F | Trachea | PD carcinoma | 31.5 | – | Yes | French et al3 |
| 11 | 21 | F | Nasopharynx | Nasopharyngeal carcinoma | 10.25 | – | Yes | French et al3 |
| 12 | 22 | F | Thymus | PD carcinoma | 3.5 | Yes | – | Kubonishi et al10 |
| 13 | 26 | M | Sinonasal | Undifferentiated carcinoma | 16.75 | Yes | – | French et al3 |
| 14 | 30 | F | Mediastinum | PD carcinoma | 3.25 | Yes | – | Engleson et al4 |
| 15 | 31 | M | Nasal cavity | SNUC | Yes | – | ||
| 16 | 34 | F | Thorax | NK | NK | Yes | – | Dang et al18 |
| 17 | 34 | M | Mediastinum | PD carcinoma | 2 | – | Yes | French et al2 |
| 18 | 35 | F | Mediastinum | PD carcinoma | 2 | Yes | – | French et al3 |
| 19 | 39 | F | Nasal cavity and sinus | PDSQC | Yes | – | ||
| 20 | 40 | F | Nasal cavity and sinus | PDSQC | Yes | – | ||
| 21 | 47 | M | Nasal cavity and sinus | SNUC | Yes | – | ||
| 22 | 78 | F | Supraglottic larynx | Undifferentiated carcinoma | Yes | – | ||
| Mean | 25.14 | 9.53 | ||||||
AW/OD, alive without disease; NK, not known; PD carcinoma, poorly differentiated carcinoma; PDSQC, poorly differentiated squamous cell carcinoma; PNET, primitive neuroectodermal tumour; SNUC, sinonasal undifferentiated carcinoma; SQC, squamous cell carcinoma.